63279-58-3Relevant articles and documents
Synthesis of extended ethynylnaphthalene-based ruthenium(II) 2,2′:6′,2″-terpyridine complexes
Benniston, Andrew C.,Mitchell, Sarah,Rostron, Sarah A.,Yang, Songjie
, p. 7883 - 7885 (2004)
A 'synthesis-at-metal' approach is used for the preparation of a new class of luminescent metal complexes having closely-spaced triplet excited states. A 'synthesis-at-metal' approach is described for the preparation of extended ethynylnaphthalene-based ruthenium(II) 2,2′:6′,2″-terpyridine complexes.
COMPOUNDS FOR A LIQUID-CRYSTALLINE MEDIUM, AND USE FOR HIGH-FREQUENCY COMPONENTS
-
Page/Page column 15, (2012/11/08)
The present invention relates to compounds of the formula (I) where one or more of the radicals A1-5 denote a 1,4-naphthylene or 1,4-anthracenylene radical, and the other parameters are as defined in Claim 1. The invention additionally includes
COMPOUNDS FOR A LIQUID-CRYSTALLINE MEDIUM, AND THE USE THEREOF FOR HIGH-FREQUENCY COMPONENTS
-
, (2012/11/07)
The present invention relates to compounds of the formula I where one or more of the radicals A1-5 denote a 1,4-naphthylene or 1,4- or 9,10-anthracenylene radical, and the other parameters are as defined in Claim 1. The invention additionally includes liquid-crystalline media which comprise the title compounds, and components for high-frequency technology which comprise these media, in particular phase shifters and microwave array antennae.
NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME
-
Page/Page column 23, (2011/09/30)
Provided are novel organic electroluminescent compounds, and organic electroluminescent devices comprising the same. Since the organic electroluminescent compounds exhibit high luminous efficiency in blue color, and excellent life property of the material, they may be used to manufacture OLEDs having very good operation life.
NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
-
Page/Page column 121-123, (2011/07/06)
The embodiments provide compounds of the general Formulae I, II, III, IV, or V as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.